| Old Articles: <Older 7111-7120 Newer> |
|---|
 |
The Motley Fool
April 28, 2005
Carl Wherrett |
Nano Moves to the Mainstream Some nanotech investments aim to bridge the commercial gap. Are they worth a look? Arrowhead Research... Competitive Technologies... Advance Nanotech...   |
The Motley Fool
April 28, 2005
Stephen D. Simpson |
Novo Nordisk Could Use a Boost Investors reacted badly to first-quarter results, but there's still a lot to like about the Danish pharmaceutical. |
The Motley Fool
April 28, 2005
W.D. Crotty |
BorgWarner Will Not Be Assimilated With a stellar quarter, the parts supplier shows its challengers that competition is futile. Investors, take note. |
The Motley Fool
April 28, 2005
Seth Jayson |
Let's Not Talk About Alderwoods This Hidden Gem of a stock continues to deliver excellent results. Shareholders hope it stays hidden a while longer. |
The Motley Fool
April 28, 2005
Jeremy MacNealy |
DuPont Steps on the Pedal DuPont continues to gain traction as sales and earnings accelerate. At this level, the giant chemical company certainly warrants further consideration for potential investors. |
The Motley Fool
April 28, 2005
Stephen D. Simpson |
Standby Drugs Sustain AstraZeneca Sales are good now, but what will a weak pipeline mean to investors in a few years? |
The Motley Fool
April 28, 2005
David Meier |
Is Tupperware Ready to Party? Better-than-expected earnings put the burp back in Tupperware's stock. |
The Motley Fool
April 28, 2005
Seth Jayson |
Pick Your Pessimism Worried that the whole market is headed down the tanko? There are still plenty of ways to profit. |
The Motley Fool
April 28, 2005
Charly Travers |
QLT's a Clutch Performer Pharma continues to deliver growth through difficult times. |
The Motley Fool
April 28, 2005
Mike Cianciolo |
Stanley Hammers Away Stanley Works powers ahead with record earnings and sales. Assuming it can improve margins a bit, this stock has a lot to offer investors. |
| <Older 7111-7120 Newer> Return to current articles. |
